Brain-penetrating neurotrophic factor mimetics: HER-096 as a disease-modifying therapy for Parkinson’s disease  

作　　者：Natalia Kulesskaya Kira M.Holmström Henri J.Huttunen 

机构地区：[1]Herantis Pharma Plc,Espoo,Finland

出　　处：《Neural Regeneration Research》2025年第4期1094-1095,共2页中国神经再生研究（英文版）

基　　金：supported by Herantis Pharma Plc and the European Innovation Council(grant acronym ReTreatPD).

摘　　要：Neurotrophic factors as a therapeutic approach in neurodegenerative diseases:A major unmet need in the field of central nervous system diseases is disease-modifying treatments.While for decades there have been various symptomatic treatments available to alleviate the symptoms of the disease,disease-modification,i.e.treatments that stop,significantly delay,or reverse the progression of the disease,has been turned out to a difficult goal to achieve.

关 键 词：DISEASES treatment THERAPEUTIC 

分 类 号：R742.5[医药卫生—神经病学与精神病学]